Renzo Galanello

发表

A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload.

Vip Viprakasit, Hugh Young Rienhoff, Paul Harmatz, 2012, Blood.

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis.

Mark A Westwood, Dudley J Pennell, D. Pennell, 2006, Blood.

Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of β-thalassemia

Gonçalo R. Abecasis, Stuart H. Orkin, Ramaiah Nagaraja, 2008, Proceedings of the National Academy of Sciences.

Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders

Maria Domenica Cappellini, Giovanni Barosi, Sante Tura, 2008, Haematologica.

A pilot trial of deferiprone for neurodegeneration with brain iron accumulation

Maurizio Melis, Giovanni Abbruzzese, Manuela Balocco, 2011, Haematologica.

On T2* Magnetic Resonance and Cardiac Iron

Dudley J Pennell, David N Firmin, Paul Kirk, 2011, Circulation.

Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study.

Vip Viprakasit, Ali T Taher, Maria Domenica Cappellini, 2012, Blood.

Seventy-five genetic loci influencing the human red blood cell

Christian Gieger, Ian J. Deary, Uwe Völker, 2012, Nature.

Screening for thalassemia: a model of success.

Maria Cristina Rosatelli, A. Cao, R. Galanello, 2002, Obstetrics and gynecology clinics of North America.

Reliable Detection of β-Thalassemia and G6PD Mutations by a DNA Microarray

Giovanni Romeo, Andres Metspalu, Ants Kurg, 2002 .

BETA THALASSEMIA

Raffaella Origa, S. Tabassum, R. Galanello, 2018, The Professional Medical Journal.

Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach

Philippe Joly, Jan Traeger-Synodinos, Webb Miller, 2011, Nature Genetics.

Amelioration of Sardinian beta0 thalassemia by genetic modifiers.

Serena Sanna, Goncalo R Abecasis, G. Abecasis, 2009, Blood.

Reliable detection of beta-thalassemia and G6PD mutations by a DNA microarray.

Giovanni Romeo, Andres Metspalu, Ants Kurg, 2002, Clinical chemistry.

BEST PRACTICE RECOMMENDATIONS

Michael Angastiniotis, John Old, Joanne Traeger-Synodinos, 2012 .

KLF1 gene mutations cause borderline HbA(2).

P. Moi, A. Cao, R. Galanello, 2011, Blood.

Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion

Juliano Lara Fernandes, Nelson Hamerschlak, A. Araújo, 2013, Revista brasileira de hematologia e hemoterapia.

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients

Vip Viprakasit, Ali T Taher, Dany Habr, 2013, American journal of hematology.

International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers

Mark Fogel, Ru San Tan, Dudley J Pennell, 2010, Journal of magnetic resonance imaging : JMRI.

Prevention of Thalassaemias and Other Haemoglobin Disorders

Bernadette Modell, Eric Jauniaux, Michael Angastiniotis, 2013 .